Analyst Ratings For NYSE:AMRX – Amneal Pharmaceuticals (NYSE:AMRX)
Today, JPMorgan Chase initiated coverage on NYSE:AMRX – Amneal Pharmaceuticals (NYSE:AMRX) with a Neutral with a price target of $18.00.
Some recent analyst ratings include
- 5/18/2018-JPMorgan Chase initiated coverage with a Neutral rating.
Recent Trading Activity for NYSE:AMRX – Amneal Pharmaceuticals (NYSE:AMRX)
Shares of NYSE:AMRX – Amneal Pharmaceuticals closed the previous trading session at 17.74 up +0.95 5.66% with 16.469999313354492 shares trading hands.